ClinicalTrials.govpublic full text
Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma
soft tissue sarcoma, neoplasms, connective and soft tissue, sarcoma metastatic, sarcoma,soft tissue, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807186
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.